White cell toxicity: A predictive marker for survival after adjuvant and neoadjuvant chemotherapy for breast cancer?

被引：0
|
作者：
Pandha, HS [1 ]
Ashley, S [1 ]
Smith, IE [1 ]
机构：
[1] Royal Marsden Hosp, Dept Med, Sutton SM2 5PT, Surrey, England
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
26
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [41] Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy
    Liu, Ying L.
    Saraf, Anurag
    Lee, Shing M.
    Zhong, Xiaobo
    Hibshoosh, Hanina
    Kalinsky, Kevin
    Connolly, Eileen P.
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (03) : 555 - 564
  • [42] In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
    Ladoire, Sylvain
    Mignot, Gregoire
    Dabakuyo, Sandrine
    Arnould, Laurent
    Apetoh, Lionel
    Rebe, Cedric
    Coudert, Bruno
    Martin, Francois
    Bizollon, Marie Helene
    Vanoli, Andre
    Coutant, Charles
    Fumoleau, Pierre
    Bonnetain, Franck
    Ghiringhelli, Francois
    JOURNAL OF PATHOLOGY, 2011, 224 (03): : 389 - 400
  • [43] Effect of time to breast cancer surgery after neoadjuvant chemotherapy on survival outcomes
    Al-Masri, Mahmoud
    Aljalabneh, Basim
    Al-Najjar, Hani
    Al-Shamaileh, Tamador
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (01) : 7 - 13
  • [44] Lymphovascular invasion is an independent predictor of survival in breast cancer after neoadjuvant chemotherapy
    Ying L. Liu
    Anurag Saraf
    Shing M. Lee
    Xiaobo Zhong
    Hanina Hibshoosh
    Kevin Kalinsky
    Eileen P. Connolly
    Breast Cancer Research and Treatment, 2016, 157 : 555 - 564
  • [45] In Situ Immune Response after Neoadjuvant Chemotherapy for Breast Cancer Predicts Survival
    Ladoire, S.
    Coudert, B.
    Fumoleau, P.
    Arnould, L.
    Ghiringhelli, F.
    CANCER RESEARCH, 2010, 70
  • [46] Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer
    Haussmann, Jan
    Budach, Wilfried
    Nestle-Kraemling, Carolin
    Wollandt, Sylvia
    Tamaskovics, Balint
    Corradini, Stefanie
    Boelke, Edwin
    Krug, David
    Fehm, Tanja
    Ruckhaeberle, Eugen
    Audretsch, Werner
    Jazmati, Danny
    Matuschek, Christiane
    CANCERS, 2022, 14 (16)
  • [47] Pathological complete response: A predictive survival factor after neoadjuvant chemotherapy in lung cancer
    Milleron, Bernard
    Westeel, Virginie
    Gounant, Valerie
    Wislez, Marie
    Quoix, Elisabeth
    BULLETIN DU CANCER, 2016, 103 (01) : 66 - 72
  • [48] Weekly adjuvant paclitaxel improves survival after standard chemotherapy in breast cancer
    Nature Clinical Practice Oncology, 2008, 5 (9): : 498 - 498
  • [49] Toxicity of adjuvant chemotherapy in elderly breast cancer patients
    Rana, F.
    Garg, P.
    Guthrie, T.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 470 - 470
  • [50] TOXICITY OF ORAL ADJUVANT CHEMOTHERAPY IN BREAST-CANCER
    MURRAY, JG
    MACINTYRE, J
    LEIBERMAN, DP
    LEAPER, DJ
    BRITISH MEDICAL JOURNAL, 1978, 1 (6110): : 408 - 409
12345